US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 245.440
  • +0.180+0.07%
Close Dec 13 16:00 ET
  • 246.570
  • +1.130+0.46%
Post 20:01 ET
31.66BMarket Cap-93.68P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-87.84%43.71M
310.49%124.16M
51.03%-81.52M
119.24%104.16M
77.42%-29.8M
411.76%359.41M
51.97%-58.99M
2.76%-166.48M
15.65%-541.27M
12.10%-131.98M
Net income from continuing operations
-175.51%-111.57M
93.88%-16.89M
62.13%-65.94M
61.08%-440.24M
33.55%-137.87M
136.40%147.75M
0.50%-276.02M
27.56%-174.1M
-32.64%-1.13B
19.72%-207.49M
Operating gains losses
-21.26%37.84M
97.84%57.01M
-2.63%8.51M
-47.23%107.94M
30.71%22.34M
-56.12%48.05M
-12.70%28.82M
-80.56%8.74M
1,285.01%204.56M
-29.85%17.09M
Depreciation and amortization
14.90%27.04M
5.31%24.69M
-2.27%25.49M
13.42%97.03M
-3.66%23.97M
13.96%23.53M
15.86%23.45M
31.86%26.08M
-4.62%85.55M
16.01%24.89M
Other non cash items
-72.60%13.87M
-20.64%19.36M
38.83%26.38M
2.20%106.99M
191.64%12.98M
82.75%50.61M
-34.83%24.4M
-45.87%19M
-22.92%104.68M
-86.53%4.45M
Change In working capital
20.38%30.73M
-176.35%-49.3M
-40.82%-121.3M
130.26%10.76M
149.67%6.79M
448.47%25.53M
93.17%64.58M
-43.65%-86.14M
78.16%-35.55M
9.50%-13.68M
-Change in receivables
65.65%-37.09M
424.58%9.64M
-97.86%410K
-92.86%-87.94M
107.26%3.87M
-181.06%-107.99M
-146.41%-2.97M
-51.75%19.15M
55.21%-45.6M
10.40%-53.27M
-Change in inventory
23.57%5.93M
242.27%6.79M
105.46%22K
153.81%18.37M
163.18%11.99M
160.82%4.8M
121.58%1.99M
-120.92%-403K
-29.23%-34.14M
-76.38%-18.98M
-Change in prepaid assets
-149.46%-8.28M
321.31%61.69M
-6,010.28%-75.46M
76.55%-9.03M
169.34%23.4M
-183.68%-3.32M
-30.82%-27.87M
95.86%-1.24M
-19.99%-38.51M
-47.89%8.69M
-Change in payables and accrued expense
-29.60%83.6M
-10.00%74.47M
94.07%-4.87M
-57.85%80.84M
-137.68%-38.67M
70.25%118.74M
21.42%82.74M
-68.20%-81.98M
117.33%191.77M
159.78%102.62M
-Change in other current liabilities
-25.78%-14.05M
0.63%-10.95M
-0.10%-12.84M
-7.72%-46.5M
-0.31%-11.49M
-8.59%-11.17M
-2.40%-11.02M
-20.19%-12.83M
-6.99%-43.17M
-6.38%-11.45M
-Change in other working capital
-97.45%624K
-979.27%-190.94M
-222.75%-28.56M
183.48%55.02M
142.85%17.69M
296.29%24.47M
13,644.30%21.72M
28.19%-8.85M
-30.77%-65.91M
-526.00%-41.28M
Cash from discontinued investing activities
Operating cash flow
-87.84%43.71M
310.49%124.16M
51.03%-81.52M
119.24%104.16M
77.42%-29.8M
411.76%359.41M
51.97%-58.99M
2.76%-166.48M
15.65%-541.27M
12.10%-131.98M
Investing cash flow
Cash flow from continuing investing activities
-181.03%-30.25M
489.53%33.94M
11.28%-67.62M
-298.61%-336.35M
-72.01%-240.66M
-103.43%-10.76M
-106.10%-8.71M
48.30%-76.22M
161.97%169.35M
66.16%-139.91M
Net PPE purchase and sale
75.47%-4.19M
49.63%-8.02M
6.61%-12.97M
13.67%-62.21M
29.24%-15.31M
-3.53%-17.09M
0.85%-15.92M
22.22%-13.89M
5.65%-72.06M
1.15%-21.64M
Net investment purchase and sale
-163.70%-6.86M
482.26%41.96M
12.32%-54.65M
-205.93%-269.7M
-89.91%-225.35M
-96.79%10.77M
-95.69%7.21M
51.87%-62.33M
232.22%254.61M
69.69%-118.66M
Net other investing changes
----
----
----
66.36%-4.44M
--0
----
----
----
-202.34%-13.19M
38,200.00%381K
Cash from discontinued investing activities
Investing cash flow
-181.03%-30.25M
489.53%33.94M
11.28%-67.62M
-298.61%-336.35M
-72.01%-240.66M
-103.43%-10.76M
-106.10%-8.71M
48.30%-76.22M
161.97%169.35M
66.16%-139.91M
Financing cash flow
Cash flow from continuing financing activities
210.08%102.76M
146.27%131.5M
-37.65%28.91M
-59.57%172.13M
-38.16%39.23M
-88.84%33.14M
76.00%53.39M
32.66%46.37M
-65.86%425.75M
-78.30%63.44M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
-49.20%254M
-52.87%117.83M
Proceeds from stock option exercised by employees
335.54%108.04M
168.81%132.78M
-38.97%25.86M
-43.14%147.46M
-45.53%30.89M
-83.79%24.81M
119.50%49.39M
56.22%42.37M
5.32%259.36M
25.92%56.71M
Net other financing activities
-163.37%-5.28M
-132.05%-1.28M
-23.70%3.05M
128.16%24.67M
107.50%8.33M
6.38%8.33M
-48.94%4M
-48.93%4M
-117.49%-87.61M
-3,940.40%-111.11M
Cash from discontinued financing activities
Financing cash flow
210.08%102.76M
146.27%131.5M
-37.65%28.91M
-59.57%172.13M
-38.16%39.23M
-88.84%33.14M
76.00%53.39M
32.66%46.37M
-65.86%425.75M
-78.30%63.44M
Net cash flow
Beginning cash position
47.16%971.19M
1.53%684.72M
-6.18%814.88M
5.64%868.56M
-3.74%1.04B
14.24%659.98M
25.76%674.41M
5.64%868.56M
64.74%822.15M
-1.92%1.08B
Current changes in cash
-69.56%116.21M
2,124.43%289.59M
38.76%-120.22M
-211.57%-60.06M
-10.92%-231.22M
-22.97%381.79M
-128.43%-14.31M
30.79%-196.32M
-83.79%53.83M
23.15%-208.45M
Effect of exchange rate changes
330.36%15.09M
-2,300.00%-3.12M
-556.85%-9.94M
186.02%6.39M
573.07%10.9M
-423.72%-6.55M
98.53%-130K
197.23%2.18M
17.61%-7.43M
153.08%1.62M
End cash Position
6.50%1.1B
47.16%971.19M
1.53%684.72M
-6.18%814.88M
-6.18%814.88M
-3.74%1.04B
14.24%659.98M
25.76%674.41M
5.64%868.56M
5.64%868.56M
Free cash flow
-88.46%39.52M
255.05%116.14M
47.61%-94.49M
106.84%41.95M
70.64%-45.1M
359.74%342.32M
46.06%-74.91M
4.59%-180.37M
14.59%-613.33M
10.70%-153.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -87.84%43.71M310.49%124.16M51.03%-81.52M119.24%104.16M77.42%-29.8M411.76%359.41M51.97%-58.99M2.76%-166.48M15.65%-541.27M12.10%-131.98M
Net income from continuing operations -175.51%-111.57M93.88%-16.89M62.13%-65.94M61.08%-440.24M33.55%-137.87M136.40%147.75M0.50%-276.02M27.56%-174.1M-32.64%-1.13B19.72%-207.49M
Operating gains losses -21.26%37.84M97.84%57.01M-2.63%8.51M-47.23%107.94M30.71%22.34M-56.12%48.05M-12.70%28.82M-80.56%8.74M1,285.01%204.56M-29.85%17.09M
Depreciation and amortization 14.90%27.04M5.31%24.69M-2.27%25.49M13.42%97.03M-3.66%23.97M13.96%23.53M15.86%23.45M31.86%26.08M-4.62%85.55M16.01%24.89M
Other non cash items -72.60%13.87M-20.64%19.36M38.83%26.38M2.20%106.99M191.64%12.98M82.75%50.61M-34.83%24.4M-45.87%19M-22.92%104.68M-86.53%4.45M
Change In working capital 20.38%30.73M-176.35%-49.3M-40.82%-121.3M130.26%10.76M149.67%6.79M448.47%25.53M93.17%64.58M-43.65%-86.14M78.16%-35.55M9.50%-13.68M
-Change in receivables 65.65%-37.09M424.58%9.64M-97.86%410K-92.86%-87.94M107.26%3.87M-181.06%-107.99M-146.41%-2.97M-51.75%19.15M55.21%-45.6M10.40%-53.27M
-Change in inventory 23.57%5.93M242.27%6.79M105.46%22K153.81%18.37M163.18%11.99M160.82%4.8M121.58%1.99M-120.92%-403K-29.23%-34.14M-76.38%-18.98M
-Change in prepaid assets -149.46%-8.28M321.31%61.69M-6,010.28%-75.46M76.55%-9.03M169.34%23.4M-183.68%-3.32M-30.82%-27.87M95.86%-1.24M-19.99%-38.51M-47.89%8.69M
-Change in payables and accrued expense -29.60%83.6M-10.00%74.47M94.07%-4.87M-57.85%80.84M-137.68%-38.67M70.25%118.74M21.42%82.74M-68.20%-81.98M117.33%191.77M159.78%102.62M
-Change in other current liabilities -25.78%-14.05M0.63%-10.95M-0.10%-12.84M-7.72%-46.5M-0.31%-11.49M-8.59%-11.17M-2.40%-11.02M-20.19%-12.83M-6.99%-43.17M-6.38%-11.45M
-Change in other working capital -97.45%624K-979.27%-190.94M-222.75%-28.56M183.48%55.02M142.85%17.69M296.29%24.47M13,644.30%21.72M28.19%-8.85M-30.77%-65.91M-526.00%-41.28M
Cash from discontinued investing activities
Operating cash flow -87.84%43.71M310.49%124.16M51.03%-81.52M119.24%104.16M77.42%-29.8M411.76%359.41M51.97%-58.99M2.76%-166.48M15.65%-541.27M12.10%-131.98M
Investing cash flow
Cash flow from continuing investing activities -181.03%-30.25M489.53%33.94M11.28%-67.62M-298.61%-336.35M-72.01%-240.66M-103.43%-10.76M-106.10%-8.71M48.30%-76.22M161.97%169.35M66.16%-139.91M
Net PPE purchase and sale 75.47%-4.19M49.63%-8.02M6.61%-12.97M13.67%-62.21M29.24%-15.31M-3.53%-17.09M0.85%-15.92M22.22%-13.89M5.65%-72.06M1.15%-21.64M
Net investment purchase and sale -163.70%-6.86M482.26%41.96M12.32%-54.65M-205.93%-269.7M-89.91%-225.35M-96.79%10.77M-95.69%7.21M51.87%-62.33M232.22%254.61M69.69%-118.66M
Net other investing changes ------------66.36%-4.44M--0-------------202.34%-13.19M38,200.00%381K
Cash from discontinued investing activities
Investing cash flow -181.03%-30.25M489.53%33.94M11.28%-67.62M-298.61%-336.35M-72.01%-240.66M-103.43%-10.76M-106.10%-8.71M48.30%-76.22M161.97%169.35M66.16%-139.91M
Financing cash flow
Cash flow from continuing financing activities 210.08%102.76M146.27%131.5M-37.65%28.91M-59.57%172.13M-38.16%39.23M-88.84%33.14M76.00%53.39M32.66%46.37M-65.86%425.75M-78.30%63.44M
Net issuance payments of debt --------------0-----------------49.20%254M-52.87%117.83M
Proceeds from stock option exercised by employees 335.54%108.04M168.81%132.78M-38.97%25.86M-43.14%147.46M-45.53%30.89M-83.79%24.81M119.50%49.39M56.22%42.37M5.32%259.36M25.92%56.71M
Net other financing activities -163.37%-5.28M-132.05%-1.28M-23.70%3.05M128.16%24.67M107.50%8.33M6.38%8.33M-48.94%4M-48.93%4M-117.49%-87.61M-3,940.40%-111.11M
Cash from discontinued financing activities
Financing cash flow 210.08%102.76M146.27%131.5M-37.65%28.91M-59.57%172.13M-38.16%39.23M-88.84%33.14M76.00%53.39M32.66%46.37M-65.86%425.75M-78.30%63.44M
Net cash flow
Beginning cash position 47.16%971.19M1.53%684.72M-6.18%814.88M5.64%868.56M-3.74%1.04B14.24%659.98M25.76%674.41M5.64%868.56M64.74%822.15M-1.92%1.08B
Current changes in cash -69.56%116.21M2,124.43%289.59M38.76%-120.22M-211.57%-60.06M-10.92%-231.22M-22.97%381.79M-128.43%-14.31M30.79%-196.32M-83.79%53.83M23.15%-208.45M
Effect of exchange rate changes 330.36%15.09M-2,300.00%-3.12M-556.85%-9.94M186.02%6.39M573.07%10.9M-423.72%-6.55M98.53%-130K197.23%2.18M17.61%-7.43M153.08%1.62M
End cash Position 6.50%1.1B47.16%971.19M1.53%684.72M-6.18%814.88M-6.18%814.88M-3.74%1.04B14.24%659.98M25.76%674.41M5.64%868.56M5.64%868.56M
Free cash flow -88.46%39.52M255.05%116.14M47.61%-94.49M106.84%41.95M70.64%-45.1M359.74%342.32M46.06%-74.91M4.59%-180.37M14.59%-613.33M10.70%-153.61M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data